Detail of the clinical trial

Title of the trial An Open-Label, Multi-Center, Global Study to Evaluate Long Term Safety and Efficacy in Patients Who are Receiving or Who Previously Received Durvalumab in Other Protocols (WAVE)
EudraCT number 2019-001402-20
Protocol number D910FC00001
Sponsor AstraZeneca AB, SE-151 85 Södertälje, Sweden
Indications Oncology
Diagnosis Long Term Safety and Efficacy in Patients
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2019
Date of approval by Institute (SÚKL) 10.12.2019
Date of approval by EC 11.11.2019
Date of initiation CT in ČR
Date of ending CT in ČR
Notice
Sites FN Olomouc,Onkologická klinika,I.P. Pavlova 185/6,Olomouc,779 00

‹‹ Back to list